MetaADEDB 2.0 @ LMMD
Cholestyramine Resin
(HGMSJMJPXGGEBP-UHFFFAOYSA-N)
Structure
SMILES
CCc1ccc(cc1)C(CCc1ccc(cc1)[N+](C)(C)C)C
Molecular Formula:
C21H30N+
Molecular Weight:
296.470
Log P:
5.1820
Hydrogen Bond Acceptor:
0
Hydrogen Bond Donor:
0
TPSA:
0
CAS Number(s):
N/A
Synonym(s)
1.
Cholestyramine Resin
2.
Cholestyramine
3.
Colestyramine
4.
Colestyramin
5.
Cuemid
6.
MK-135
7.
Quantalan
8.
Questran
9.
Cholestyramine Resins
10.
Cholestyramines
11.
Colestyramines
12.
Colestyramins
13.
Cuemids
14.
MK 135
15.
MK135
16.
Quantalans
17.
Questrans
18.
Resin, Cholestyramine
19.
Resins, Cholestyramine
External Link(s)
MeSHD002792
PubChem Compound70695641
CHEMBLCHEMBL2110633
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product taste abnormalFAERS: 36US FAERS
2Product use issueFAERS: 21US FAERS
3Drug ineffective for unapproved indicationFAERS: 14US FAERS
4Product solubility abnormalFAERS: 14US FAERS
5NauseaFAERS: 11
Canada Vigilance: 1		Canada Vigilance
US FAERS
6Product quality issueFAERS: 9US FAERS
7VomitingFAERS: 9US FAERS
8ConstipationFAERS: 8US FAERS
9Product residue presentFAERS: 8US FAERS
10Drug ineffectiveFAERS: 7
Canada Vigilance: 1		Canada Vigilance
US FAERS
11Product use in unapproved indicationFAERS: 7US FAERS
12RetchingFAERS: 7US FAERS
13DysgeusiaFAERS: 6US FAERS
14MalaiseFAERS: 6US FAERS
15No adverse eventFAERS: 6US FAERS
16Throat irritationFAERS: 6US FAERS
17Product physical consistency issueFAERS: 5US FAERS
18Product use complaintFAERS: 5US FAERS
19Abdominal PainFAERS: 4US FAERS
20ChokingFAERS: 4US FAERS
21DizzinessFAERS: 4US FAERS
22FlatulenceFAERS: 4US FAERS
23HeadacheFAERS: 4US FAERS
24Oropharyngeal painFAERS: 4US FAERS
25Product contamination physicalFAERS: 4US FAERS
26Abdominal discomfortFAERS: 3US FAERS
27Product physical issueFAERS: 3US FAERS
28Product substitution issueFAERS: 3US FAERS
29Weight decreasedFAERS: 3US FAERS
30Adverse eventFAERS: 2US FAERS
31ArthralgiaFAERS: 2US FAERS
32AstheniaFAERS: 2US FAERS
33Blood glucose increasedFAERS: 2US FAERS
34Burning sensationFAERS: 2US FAERS
35Chest PainFAERS: 2US FAERS
36Intestinal ObstructionFAERS: 2US FAERS
37Lip swellingFAERS: 2US FAERS
38PainFAERS: 2US FAERS
39Pharmaceutical product complaintFAERS: 2US FAERS
40TremorFAERS: 2US FAERS
41UrticariaFAERS: 2US FAERS
42Wrong technique in product usage processFAERS: 2US FAERS
43AbasiaFAERS: 1US FAERS
44Abdominal symptomFAERS: 1US FAERS
45AgeusiaFAERS: 1US FAERS
46AlopeciaFAERS: 1US FAERS
47AnxietyFAERS: 1US FAERS
48ArthritisFAERS: 1US FAERS
49Back PainFAERS: 1US FAERS
50Blood glucose fluctuationFAERS: 1US FAERS
51Blood phosphorus increasedFAERS: 1US FAERS
52ChillsFAERS: 1US FAERS
53DeliriumFAERS: 1US FAERS
54DroolingFAERS: 1US FAERS
55EpistaxisFAERS: 1US FAERS
56ErythemaFAERS: 1US FAERS
57Euphoric moodFAERS: 1US FAERS
58Feeling abnormalFAERS: 1US FAERS
59Foreign body in respiratory tractFAERS: 1US FAERS
60GlossitisFAERS: 1US FAERS
61Head discomfortFAERS: 1US FAERS
62InfectionFAERS: 1US FAERS
63Medication ErrorFAERS: 1US FAERS
64MyalgiaFAERS: 1US FAERS
65NasopharyngitisFAERS: 1US FAERS
66OverdoseFAERS: 1US FAERS
67Poor quality drug administeredFAERS: 1US FAERS
68Product difficult to swallowFAERS: 1US FAERS
69PruritusFAERS: 1US FAERS
70PsoriasisFAERS: 1US FAERS
71Rectal dischargeFAERS: 1US FAERS
72SinusitisFAERS: 1US FAERS
73StomatitisFAERS: 1US FAERS
74Therapeutic response unexpectedFAERS: 1US FAERS
75ThirstFAERS: 1US FAERS
76UlcerFAERS: 1US FAERS
77Unevaluable eventFAERS: 1US FAERS
78Wrong patient received medicationFAERS: 1US FAERS
79DisorientationCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.